Medizinische Universität Innsbruck

Moving beyond the hospital: in-depth characterization of daily-life mobility in patients with atypical Parkinsonian disorders (2026) Sidoroff V, Moradi H, Prigent G, Jagusch F, Teckenburg IB, Asalian M, Hergenroeder-Lenzner N, et al. Journal article Clinical and treatment-related predictors of complete response after total neoadjuvant therapy for rectal cancer in a large multicenter analysis (2026) Wurschi GW, Schneider M, Becker JN, Frerker B, Vorbach SM, Ehret F, Diefenhardt M, et al. Journal article Heterogeneity of Estimated GFR Slopes According to Etiology, Estimated GFR and Urinary Albumin-to-Creatinine Ratio in a Large Cohort of Patients With CKD (2026) Behning C, Schultheiss UT, Nadal J, Meiselbach H, Schönherr S, Forer L, Schaeffner E, et al. Journal article Multidisciplinary guidelines on renal replacement therapy in intensive care medicine (2026) Meersch-Dini M, Abu-Tair M, Bayer M, Brinkmann A, Bellmann R, Brunkhorst F, Custodis F, et al. Journal article, Review article Erratum to “CLAUDIUS Study: Risk of materno-fetal transmission of melanoma cells in pregnant women with high grade melanoma – A retrospective multicenter study and literature review” [EJC Skin Cancer 1 (2023) 100005] (EJC Skin Cancer (2023) 1, (S2772611823000058), (10.1016/j.ejcskn.2023.100005)) (2026) Wiedemann SV, Müller V, Toth B, Erdmann M, Bühler B, Dugas-Breit S, Schatton K, et al. Journal article, Erratum Oxaliplatin-induced neuropathy after total neoadjuvant therapy for rectal cancer: Dose–response relationship and impact on quality of life (2026) Wurschi GW, Hinz A, Schneider M, Becker JN, Frerker B, Vorbach SM, Ehret F, et al. Journal article Editorial: Autoimmune diseases of the central nervous system (2026) Mader S, Reindl M Journal article Therapy-Associated Neuroendocrine Prostate Cancer (tNEPC): A Diagnostic and Therapeutic Challenge in Uro-Oncology with Emerging Clinical Implications Therapieinduziertes neuroendokrines Prostatakarzinom (tNEPC) – Eine Herausforderung in der Uro-Onkologie: Diagnostik, klinische Relevanz und therapeutische Perspektiven (2026) von Amsberg G, Hartmann A, Eckstein M, Heidegger I Journal article, Review article Treatment differences in IDH–wildtype glioma – the impact of surgery and adjuvant therapy (2026) Keric N, Krenzlin H, Lange F, Dauth A, Freyschlag CF, Schnellg O, Misch M, et al. Journal article Delta-like ligand 3 expression in isocitrate dehydrogenase-mutant and isocitrate dehydrogenase-wildtype glioma is largely retained at recurrence, supporting its potential as a therapeutic target (2026) Luning R, Maas SL, French PJ, Hoogstrate Y, van Hijfte L, Head R, de Heer I, et al. Journal article